Susceptibility testing interpretive criteria for levofloxacin when testing respiratory pathogens, Haemophilus influenzae and Moraxella catarrhalis

This publication has 11 references indexed in Scilit:

• A survey of β-lactamase-producing Haemophilus influenzae an evaluation of 5750 isolates
  Diagnostic Microbiology and Infectious Disease, 1995
• In vitro activities of 12 orally administered antimicrobial agents against four species of bacterial respiratory pathogens from U.S. Medical Centers in 1992 and 1993
  Antimicrobial Agents and Chemotherapy, 1994
• Prevalence of important pathogens and antimicrobial activity of parenteral drugs at numerous medical centers in the United States I. Study on the threat of emerging resistances: Real or perceived?
  Diagnostic Microbiology and Infectious Disease, 1994
• Determination of antimicrobial susceptibilities of Canadian isolates of Haemophilus influenzae and characterization of their beta-lactamases. Canadian Haemophilus Study Group
  Antimicrobial Agents and Chemotherapy, 1994
• Ciprofloxacin-Resistant Haemophilus Influenzae Infection in a Patient with Chronic Lung Disease
  Annals of Pharmacotherapy, 1993
• Haemophilus test medium (HTM) susceptibility methods: Results of evaluations of reproducibility, stability, and medium quality
  Antimicrobic Newsletter, 1993
• In vitro and in vivo antibacterial activities of levofloxacin (l-ofloxacin), an optically active ofloxacin
  Antimicrobial Agents and Chemotherapy, 1992
• Problems with current recommendations for susceptibility testing of Haemophilus influenzae
  Antimicrobial Agents and Chemotherapy, 1990
• In vitro activity of S-ofloxacin
  Antimicrobial Agents and Chemotherapy, 1989
• Synthesis and antibacterial activities of optically active ofloxacin
  Antimicrobial Agents and Chemotherapy, 1986